EMERYVILLE, Calif., Sept. 12 /PRNewswire-FirstCall/ -- Bionovo, Inc. (Nasdaq: BNVI), a pharmaceutical company focused on the discovery and development of safe and effective drugs in the areas of women's health and cancer, announced today that Dr. Isaac Cohen, Chairman and CEO, and Dr. Mary Tagliaferri, President and Chief Medical Officer of Bionovo, will be presenting at the Merriman Curhan Ford's 5th annual Investor Summit on September 15, 2008 at 2:15 p.m. This event will be held at the Mark Hopkins InterContinental Hotel in San Francisco.
The presentation will be webcast and can be viewed via Bionovo's website at http://webcasts.bionovo.com. A webcast replay will become available shortly after the presentation ends and will continue to be accessible for 90 days via Bionovo's website.
More information about the conference can be found at: http://mcfco.com/AboutUs/Conferences_YearBook.php?ConferenceName=InvestorSu mmi t2008
About Bionovo, Inc.
Bionovo is a pharmaceutical company focused on the discovery and
development of safe and effective treatments for women's health and cancer,
markets with significant unmet needs and billions in potential annual
revenue. The company applies its expertise in the biology of menopause and
cancer to design new drugs derived from botanical sources which have novel
mechanisms of action. Based on the results of early and mid-stage clinical
trials, Bionovo believes they have discovered new classes of drug
candidates within their rich pipeline with the potential to be leaders in
their markets. Bionovo is headquartered in Em
|SOURCE Bionovo, Inc.|
Copyright©2008 PR Newswire.
All rights reserved